![]() While this might translate into heavier competition for less money from overly cautious investors in the short run, the long-term outlook for biotech is exciting.īottom line: you’re going to have to work harder for funding opportunities. ![]() In the first quarter of 2020, funding is down about 16% over the fourth quarter of 2019. With the threat – and manifestation – of pandemics becoming frequent events in today’s globally interactive population, biotech is a thriving business.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |